Financials data is unavailable for this security.
View more
Year on year Eton Pharmaceuticals Inc grew revenues 48.90% from 21.25m to 31.64m while net income improved from a loss of 9.02m to a smaller loss of 936.00k.
Gross margin | 59.48% |
---|---|
Net profit margin | -21.31% |
Operating margin | -20.00% |
Return on assets | -21.31% |
---|---|
Return on equity | -44.30% |
Return on investment | -38.27% |
More ▼
Cash flow in USDView more
In 2023, Eton Pharmaceuticals Inc increased its cash reserves by 31.17%, or 5.08m. The company earned 6.82m from its operations for a Cash Flow Margin of 21.54%. In addition the company used 775.00k on investing activities and also paid 957.00k in financing cash flows.
Cash flow per share | -0.2212 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.5229 |
---|---|
Tangible book value per share | 0.2851 |
More ▼
Balance sheet in USDView more
Current ratio | 1.40 |
---|---|
Quick ratio | 1.28 |
Total debt/total equity | 0.346 |
---|---|
Total debt/total capital | 0.2571 |
More ▼